Navigation Links
Cancer Drug May Boost Risk of Gastrointestinal Perforation

Review of trials finds Avastin with chemo doubles odds

MONDAY, May 25 (HealthDay News) -- The use of the drug bevacizumab (Avastin) in combination with chemotherapy greatly increases the risk of gastrointestinal perforations in cancer patients, new research has found.

These perforations are potentially life-threatening holes in the wall of the stomach, small intestine or large bowel.

Bevacizumab is designed to slow the growth of tumors by cutting off their blood supply. Concerns have been raised about bevacizumab and gastrointestinal (GI) perforation, but so far no clinical trials have proved a significant association, according to a news release.

In this new study, Dr. Sanjaykumar Hapani and colleagues at Stony Brook University Cancer Center in New York analyzed findings from 17 trials that included a total of 12,294 patients with a variety of solid tumors. The overall incidence of GI perforation among the patients was 0.9 percent (the death rate was 21.7 percent), but patients who took bevacizumab were twice as likely to develop GI perforations.

The researchers also found that the risk of GI perforations among patients taking bevacizumab was dose dependent. Compared to patients who didn't take the drug, those who took 2.5 mg/kg per week of bevacizumab were 61 percent more likely to develop GI perforations, while those who took 5 mg/kg per week of the drug had a 167 percent higher risk.

The risk of GI perforation associated with bevacizumab also varied according to tumor type, the study authors found. Patients with advanced colorectal cancer and renal cell cancer had the highest risk, while those with pancreatic cancer had the lowest risk.

"As bevacizumab is used extensively in routine cancer treatment and in clinical trials, it will be increasingly important to recognize symptoms indicating perforation and intervene promptly to reduce morbidity and fatality," the researchers concluded. "Our study might help to identify a subset of patients receiving bevacizumab at high risk of bevacizumab-associated perforation."

The study appears online and in the June print issue of The Lancet Oncology.

More information

The MedlinePlus Medical Encyclopedia has more about GI perforation.

-- Robert Preidt

SOURCE: The Lancet Oncology, news release, May 24, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Research Sheds Light on Breast Cancer Prognosis
2. Sexually Transmitted HPV Linked to Certain Head & Neck Cancers
3. Breast MRI detects additional unsuspected cancers not seen on mammography or ultrasound
4. Many Black Women Refuse Breast Cancer Treatments
5. Is there any association between COX2 and colon cancer?
6. Low Vitamin D Levels May Initiate Cancer Development
7. Advanced Prostate Cancer Deadlier in Younger Men
8. Younger men with advanced prostate cancer have shorter survival times
9. African-American women with advanced breast cancer often forego vital treatment
10. Key protein may explain the anti-aging and anti-cancer benefits of dietary restriction
11. Viral Genetics Has Option Under Issued Key Patent for Cancer Drug
Post Your Comments:
Related Image:
Cancer Drug May Boost Risk of Gastrointestinal Perforation
(Date:10/13/2015)... ... October 13, 2015 , ... ... first commercially-available next-generation sequencing laboratory test for bacterial vaginosis- a significant women's ... in Vancouver, BC, Canada. , In a presentation entitled: "The Microbiome ...
(Date:10/12/2015)... ... October 13, 2015 , ... Career Step, ... the release of its new Professional Medical Coding and Billing with Applied PCS ... ICD-10-CM and ICD-10-PCS code sets, earn the Certified Professional Coder (CPC) and Certified ...
(Date:10/12/2015)... ... 12, 2015 , ... According to an article from ... particularly in the area of track and field, are at a significantly higher ... peers in the same age group. Dr. Steven Meier of Meier Orthopedic Sports ...
(Date:10/12/2015)... ... 12, 2015 , ... According to an article published by Texas ... Texas recommended that any high-rises in the city limits that do not have fire ... article explains that it wasn’t until 1982 that the city started requiring fire sprinklers ...
(Date:10/12/2015)... ... October 12, 2015 , ... AcousticSheep LLC, creators of the ... honor of Breast Cancer Awareness Month. During the month of October, for ... SleepPhones® Classic product to a breast cancer patient at the Cleveland Clinic. , ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... -- Use this report to: - Learn ... the medical membrane devices market. - Analyze the present ... medical membrane devices market including hemodialyzers, membrane oxygenators, intravenous ... devices. - Gain information on newly approved products, recalls ... Use this report to: - Learn about the performance, ...
(Date:10/12/2015)... and CRANBURY, N.J. , Oct. ... LLP announces that a securities fraud class ... for the District of New Jersey.  The complaint alleges ... FOLD) violated the Securities Exchange Act of 1934 between ... materially false and misleading statements about Amicus Therapeutics, business ...
(Date:10/12/2015)... , Oct. 12, 2015  MiMedx Group, Inc. ... utilizing human amniotic tissue and patent-protected processes to develop ... Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and the ... results for the third quarter of 2015, its guidance ... Company has secured a $50 million Senior Secured Credit ...
Breaking Medicine Technology: